menu
    • menu

    Company profile for EirGenix

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    SERVICES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    EirGenix is a leading contract development and manufacturing organization (CDMO) offering top-notch and affordable services. We assist our clients in every stage of biopharmaceutical development, from pre-clinical research to commercial manufacturing, including analytical testing and compliance with current Good Manufacturing Practices (cGMP). Our expertise also extends to the specialized field of biosimilar development. Curre...
    EirGenix is a leading contract development and manufacturing organization (CDMO) offering top-notch and affordable services. We assist our clients in every stage of biopharmaceutical development, from pre-clinical research to commercial manufacturing, including analytical testing and compliance with current Good Manufacturing Practices (cGMP). Our expertise also extends to the specialized field of biosimilar development. Currently, EirGenix is actively developing seven products, each with unique therapeutic potential. Among these, four are antibody products targeting the HER2 gene variance, aiming to address specific medical needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EirGenixTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    Xizhi District, New Taipei City
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.eirgenix.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eirgenix-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eirgenix Signs Commercial Licensing Deal For HER2 Biosimilar
    Eirgenix Signs Commercial Licensing Deal For HER2 Biosimilar

    12 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eirgenix-signed-the-commercial-licensinse-agreement-for-its-second-her2-biosimilar-asset-eg1206a-302612772.html

    PR NEWSWIRE
    12 Nov 2025
    Share Share
    EirGenix's Breast Cancer Biosimilar Receives Marketing Authorization by EC
    EirGenix's Breast Cancer Biosimilar Receives Marketing Authorization by EC

    22 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eirgenixs-breast-cancer-biosimilar-receives-marketing-authorization-by-ec-301996431.html

    PR NEWSWIRE
    22 Nov 2023
    Share Share
    EirGenix's Second Breast Cancer Biosimilar EG1206A Successfully Reaches Phase 1
    EirGenix's Second Breast Cancer Biosimilar EG1206A Successfully Reaches Phase 1

    02 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eirgenixs-second-breast-cancer-biosimilar-eg1206a-successfully-reaches-phase-1-clinical-trial-objectives-301813987.html

    PR NEWSWIRE
    02 May 2023
    Share Share
    Sandoz submits BLA for proposed biosimilar trastuzumab to US FDA
    Sandoz submits BLA for proposed biosimilar trastuzumab to US FDA

    22 Dec 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=144777&sid=2

    PHARMABIZ
    22 Dec 2021
    Share Share
    Positive Phase III Clinical Results for EirGenix's Proposed Trastuzumab
    Positive Phase III Clinical Results for EirGenix's Proposed Trastuzumab

    24 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/positive-phase-iii-clinical-results-for-eirgenixs-proposed-trastuzumab-biosimilar-301255022.html

    PRNEWSWIRE
    24 Mar 2021
    Share Share
    Shorla nabs $8.3M to bring improved cancer meds to the U.S.
    Shorla nabs $8.3M to bring improved cancer meds to the U.S.

    02 Jun 2020

    // Amirah Al Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ireland-s-shorla-nabs-8-3m-to-bring-improved-cancer-meds-to-u-s

    Amirah Al Idrus FIERCE BIOTECH
    02 Jun 2020
    Share Share

    Services

    Upload your portfolio for free, ask us

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search